Disc Medicine, Inc.
IRONAs of the close on Sep 25, 2026
Price
$65.24
Market cap
$2.5B
P/E (diluted TTM)
—
Not meaningful: the last four quarters were a loss
EPS (TTM)
−$6.60
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Disc Medicine, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 30, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| ANTIPODES PARTNERS Ltd | 2026-03-31 | 476 | $30.4K | SEC filing |
| Jump Financial, LLC | 2026-03-31 | 81,829 | $5.23M | SEC filing |
| Swiss National Bank | 2026-03-31 | 48,000 | $3.07M | SEC filing |
| Engineers Gate Manager LP | 2026-03-31 | 9,270 | $593K | SEC filing |
| SBI Securities Co., Ltd. | 2026-03-31 | 1 | $64 | SEC filing |
| ALGERT GLOBAL LLC | 2026-03-31 | 22,680 | Not shown | SEC filing |
| TWIN PEAKS WEALTH ADVISORS, LLC | 2026-03-31 | 1 | $64 | SEC filing |
| NEW YORK STATE COMMON RETIREMENT FUND | 2026-03-31 | 8,576 | $548K | SEC filing |
| WELLS FARGO & COMPANY/MN | 2026-03-31 | 14,690 | $939K | SEC filing |
| Freestone Grove Partners LP | 2026-03-31 | 68,687 | $4.39M | SEC filing |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 2026-03-31 | 32,493 | $2.08M | SEC filing |
| Checkpoint Capital L.P. | 2026-03-31 | 286,661 | $18.3M | SEC filing |
| FIFTH THIRD BANCORP | 2026-03-31 | 29 | $1.86K | SEC filing |
| Foresite Capital Management V, LLC | 2026-03-31 | 374,069 | $23.9M | SEC filing |
| True Wealth Design, LLC | 2026-03-31 | 1 | $64 | SEC filing |
| BOOTHBAY FUND MANAGEMENT, LLC | 2026-03-31 | 21,378 | $1.37M | SEC filing |
| JONES FINANCIAL COMPANIES LLLP | 2026-03-31 | 1,627 | $97.8K | SEC filing |
| Casdin Capital, LLC | 2026-03-31 | 65,000 | $4.16M | SEC filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2026-03-31 | 251,195 | $16.1M | SEC filing |
| SPHERA FUNDS MANAGEMENT LTD. | 2026-03-31 | 53,538 | $3.42M | SEC filing |
- Each value is checked against Disc Medicine, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Disc Medicine, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Disc Medicine, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-12-16 · Bitterman Kevin: Larger than 153 of the 160 other insider sales of Common Stock on file. SEC filing
- 2025-12-15 · Bitterman Kevin: Larger than 150 of the 160 other insider sales of Common Stock on file. SEC filing
- 2025-10-22 · Blavatnik Len: Larger than all 160 other insider sales of Common Stock on file. SEC filing
- 2025-10-08 · Bitterman Kevin: Larger than 145 of the 160 other insider sales of Common Stock on file. SEC filing
- 2025-08-13 · Bitterman Kevin: Larger than 144 of the 160 other insider sales of Common Stock on file. SEC filing
- 2025-07-23 · Bitterman Kevin: Larger than 151 of the 160 other insider sales of Common Stock on file. SEC filing
- 2025-07-09 · Quisel John D: Larger than 152 of the 160 other insider sales of Common Stock on file. SEC filing
- 2025-03-12 · Ashiya Mona: Larger than 154 of the 160 other insider sales of Common Stock on file. SEC filing
- 2025-03-12 · Ashiya Mona: Larger than 148 of the 160 other insider sales of Common Stock on file. SEC filing
- 2025-03-12 · ORBIMED ADVISORS LLC: Larger than 148 of the 160 other insider sales of Common Stock on file. SEC filing
- 2025-03-12 · ORBIMED ADVISORS LLC: Larger than 154 of the 160 other insider sales of Common Stock on file. SEC filing
- 2025-03-10 · ORBIMED ADVISORS LLC: Larger than 158 of the 160 other insider sales of Common Stock on file. SEC filing
- 2025-03-10 · Ashiya Mona: Larger than 146 of the 160 other insider sales of Common Stock on file. SEC filing
- 2025-03-10 · ORBIMED ADVISORS LLC: Larger than 146 of the 160 other insider sales of Common Stock on file. SEC filing
- 2025-03-10 · Ashiya Mona: Larger than 156 of the 160 other insider sales of Common Stock on file. SEC filing
- 2025-03-10 · Ashiya Mona: Larger than 158 of the 160 other insider sales of Common Stock on file. SEC filing
- 2025-03-10 · ORBIMED ADVISORS LLC: Larger than 156 of the 160 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-29 | Khara Rahul · Chief Legal Officer | Common Stock | S — Open market or private sale | −1,649 | 75.00 | SEC filing |
| 2026-06-26 | Khara Rahul · Chief Legal Officer | Common Stock | S — Open market or private sale | −851 | 75.00 | SEC filing |
| 2026-06-26 | Yu Jonathan Yen-Wen · Chief Operating Officer | Common Stock | S — Open market or private sale | −300 | 72.50 | SEC filing |
| 2026-06-22 | Yu Jonathan Yen-Wen · Chief Operating Officer | Common Stock | S — Open market or private sale | −9,700 | 72.66 | SEC filing |
| 2026-06-18 | Quisel John D · Chief Executive Officer | Common Stock | S — Open market or private sale | −22,927 | 69.92 | SEC filing |
| 2026-06-18 | Khara Rahul · Chief Legal Officer | Common Stock | S — Open market or private sale | −5,400 | 69.94 | SEC filing |
| 2026-06-18 | Khara Rahul · Chief Legal Officer | Common Stock | S — Open market or private sale | −1,600 | 70.73 | SEC filing |
| 2026-06-18 | Quisel John D · Chief Executive Officer | Common Stock | S — Open market or private sale | −1,551 | 71.61 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-29 | Khara Rahul · Chief Legal Officer | Common Stock | M — Exercise or conversion of derivative security | +1,649 | SEC filing |
| 2026-06-29 | Khara Rahul · Chief Legal Officer | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −1,649 | SEC filing |
| 2026-06-26 | Khara Rahul · Chief Legal Officer | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −851 | SEC filing |
| 2026-06-26 | Yu Jonathan Yen-Wen · Chief Operating Officer | Common Stock | M — Exercise or conversion of derivative security | +300 | SEC filing |
| 2026-06-26 | Yu Jonathan Yen-Wen · Chief Operating Officer | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −300 | SEC filing |
| 2026-06-26 | Khara Rahul · Chief Legal Officer | Common Stock | M — Exercise or conversion of derivative security | +851 | SEC filing |
| 2026-06-22 | Yu Jonathan Yen-Wen · Chief Operating Officer | Common Stock | M — Exercise or conversion of derivative security | +9,700 | SEC filing |
| 2026-06-22 | Yu Jonathan Yen-Wen · Chief Operating Officer | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −9,700 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.